Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SiriusPoint Ltd. (SPNT) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. SiriusPoint is a Bermuda-incorporated global underwriter of insurance and reinsurance whose common shares and 8.00% Resettable Fixed Rate Preference Shares, Series B, are listed on the New York Stock Exchange under the symbols SPNT and SPNT PB. Its filings provide detailed insight into segment performance, capital structure, governance, and material corporate events.
Through its Form 8-K filings, SiriusPoint reports results of operations and financial condition, furnishing earnings press releases, financial supplements, and investor presentations for periods such as the second and third quarters. These documents explain Core results across the Insurance & Services and Reinsurance segments, combined ratios, underwriting income, Core net services income, and book value measures, as well as the impact of catastrophe losses and prior-year reserve development.
The company also uses Form 8-K to disclose material transactions and strategic actions, including the definitive agreement and subsequent completion of the sale of ArmadaCorp Capital, LLC, the holding company of supplemental health insurance program manager ArmadaCare, and the agreement to sell its equity stake in Arcadian Holdings Limited to an acquisition vehicle affiliated with Lee Equity Partners. Related exhibits often include press releases describing associated capacity agreements that extend underwriting authority for Arcadian through at least the end of 2031.
Additional filings cover governance and compensation matters, such as the adoption of the SiriusPoint Ltd. Executive Severance Plan, appointments and resignations of executive officers and directors, and determinations about director independence. SiriusPoint also files 8-Ks to announce quarterly cash dividends on its Series B preference shares, specifying dividend amounts, record dates, and payment dates.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the significance of each report. Users can quickly see which filings relate to earnings (such as 10-Q and 10-K when available), which detail insider and executive changes, and which describe major transactions or capital actions, providing a structured view of SiriusPoint’s regulatory history.
SiriusPoint Ltd reported that Group Chief Underwriting Officer Anthony Shapella had 1,009 Common Shares withheld on April 14, 2026 to cover current tax liabilities tied to the vesting of restricted share units. The shares were valued at $22.67 each. After this tax-withholding disposition, Shapella directly holds 38,958 Common Shares, which the disclosure notes include restricted shares.
SiriusPoint Ltd. is asking shareholders to vote at its 2026 virtual annual general meeting on May 20, 2026. Key proposals include electing two Class I directors, an advisory approval of named executive officer pay, ratifying PricewaterhouseCoopers as independent auditor, and approving the SiriusPoint SharePlan.
The proxy outlines an 11‑member mostly independent, classified board, detailed committee structures, director compensation and ownership guidelines, and a broad risk and cybersecurity oversight framework. It also highlights SiriusPoint’s global specialty (re)insurance business, 2025 capital base, and sustainability, climate and stakeholder‑engagement initiatives.
SiriusPoint Ltd has filed an initial insider ownership report for director Sabra R. Purtill on Form 3. This filing identifies Purtill as a director and reporting person for the company. The provided data show no transactions or derivative positions disclosed in connection with this initial statement.
SiriusPoint Ltd. has appointed Sabra R. Purtill to its Board of Directors effective March 25, 2026, as a Class I director serving until the annual general meeting scheduled for May 20, 2026. She brings 40 years of insurance and financial services experience and has held senior roles at AIG, Hartford Financial Services Group, Assured Guaranty and ACE Limited (now Chubb.
The Board determined that Ms. Purtill is an independent director and an “audit committee financial expert”. She will serve on the Audit Committee and the Risk & Capital Management Committee and receive the same compensation as other non‑employee directors. Directors Franklin (Tad) Montross IV and Peter W. H. Tan will not stand for reelection, with their Board and committee service ending after the May 20, 2026 annual meeting; their decision is stated as not due to any disagreement with the company.
SiriusPoint Ltd ownership update: The Vanguard Group filed an amendment disaggregating certain subsidiaries and reports 0 shares beneficially owned of Common Stock, representing 0% of the class. The filing states the change resulted from an internal realignment effective January 12, 2026.
SiriusPoint Ltd. outlined the exit terms for Rob Gibbs, President & Chief Executive Officer of SiriusPoint International Insurance Corporation (publ), following his previously announced departure. SiriusPoint International and Mr. Gibbs signed a Settlement Agreement on March 17, 2026.
Under the agreement, Mr. Gibbs will receive a severance payment of 401,700 GBP, inclusive of payment in lieu of his six‑month notice period, any pro‑rated 2026 bonus entitlement, and contractual severance, paid in 12 equal monthly installments after his last employment day on April 30, 2026. He will not receive a bonus for 2025.
SiriusPoint International will seek to continue his private medical insurance coverage through April 30, 2027 and life assurance coverage through December 31, 2026, and will pay 3,000 GBP in lieu of life assurance for the period from January 1 through April 30, 2027, all subject to applicable taxes and National Insurance. The agreement includes ongoing confidentiality, non‑disparagement, non‑compete and non‑solicitation obligations and a general release of claims by Mr. Gibbs.
SiriusPoint Ltd. is reorganizing its operations into four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division that includes Lloyd’s. The company is combining its North America and International Programs into a single Global P&C Programs division led by Patrick Charles.
The new London Market Specialty division, highlighting the importance of SiriusPoint’s London platform and Syndicate 1945, will be led by David Govrin, who also serves as CEO Global Reinsurance. As part of these changes, Rob Gibbs, President & CEO of SiriusPoint International, will leave the company under a mutual separation agreement based on the Executive Severance Plan. The company furnished a press release as Exhibit 99.1 describing these structural changes and the leadership transition.
Govrin David E. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd Group President David E. Govrin reported an equity award of 315,738 common shares at a stated price of $0.0000 per share. A footnote explains this represents 315,738 Performance Restricted Share Units achieved at 200% of target from a 2023–2025 grant under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan, scheduled to vest on April 14, 2026. Following this award, Govrin directly holds 833,713 common shares, which the disclosure notes includes restricted shares.
SiriusPoint Ltd Group Chief Underwriting Officer Anthony Shapella reported a tax-related share disposition. On February 27, 2026, 2,248 common shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this, he directly owns 39,967 common shares, including restricted shares.